Commentary on Anand et al .

Califf RM Ellenberg SS . Statistical approaches and policies for the operations of Data and Safety Monitoring Committees. Am Heart J 2001; 141: 301–305.

Fisher L Klibaner M . Regulatory issues for Data and Safety Monitoring Committees. Am Heart J 2001; 141: 536–541.

Packer M Wittes J Stump D . Terms of reference for Data and Safety Monitoring Committees. Am Heart J 2001; 141: 542–547.

Pocock S Furberg CD . Procedures of data and safety monitoring committees. Am Heart J 2001; 141: 289–294.

Anand S Wittes J Yusuf S . What information should a sponsor of a randomized trial receive during its conduct? Clin Trials 2011. PE: Please update the volume and page numbers for Ref. 5 at the issue stage.

Califf RM Zarin DA Kramer JM . The clinical trials enterprise in the United States as revealed by the development of ClinicalTrials.gov as an integrated database. 2011 (under review).

Tricoci P Allen JM Kramer JM Califf RM Smith SC Jr . Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009; 301: 831–41.

Lee DH Vielemeyer O. Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. Arch Intern Med 2011; 171: 18–22.

Olsen LA Aisner D McGinnis JM (eds). Institute of Medicine Roundtable on Evidence-Based Medicine. The Learning Healthcare System (Workshop Summary). Washington, DC: National Academies Press, 2007.